AAV2-7M8 Serotype
Engineered AAV2 variant selected through directed evolution in human hepatocyte xenograft mice. Contains a seven-amino acid insertion at position 588 in the capsid.
| Tropism | Liver (human hepatocytes), enhanced human-specific transduction |
|---|
Characteristics
20-fold enhanced human hepatocyte transduction versus wild-type AAV2. Demonstrates species-specific tropism improvements. Selected using humanized mouse model platform. Seven-amino acid peptide insertion (LALGETTRP) at capsid position 588.
Applications
Liver-directed gene therapy for metabolic disorders. Hemophilia A and B. Preclinical model for humanized AAV evolution strategies.
Sequence1 bp
Sign in to view the full sequence.
Sign inReferences
- 1.Lisowski et al. (2014). Selection and evaluation of clinically relevant AAV variants in a xenograft liver model. Nature — Lisowski 2014 AAV2-7m8
